Trial Outcomes & Findings for Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma (NCT NCT00897910)
NCT ID: NCT00897910
Last Updated: 2016-01-11
Results Overview
TERMINATED
6 participants
Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.
2016-01-11
Participant Flow
Subjects were recruited from the outpatient clinics or inpatient service of Karmanos Cancer Center by physicians in the Department of Hematology and Medical Oncology, between April 2008 and October 2009.
All 6 consented subjects had blood drawn during their routine labs. No bone marrow samples were collected.
Participant milestones
| Measure |
Collection of Circulating Blood and Bone Marrow.
|
|---|---|
|
Overall Study
STARTED
|
6
|
|
Overall Study
COMPLETED
|
6
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
Baseline characteristics by cohort
| Measure |
Collection of Circulating Blood and Bone Marrow.
n=6 Participants
|
|---|---|
|
Age, Continuous
|
53 years
STANDARD_DEVIATION 0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
6 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.Outcome measures
Outcome data not reported
Adverse Events
Collection of Circulating Blood and Bone Marrow.
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Zaid S. Al-Kadhimi, M.D.
Barbara Ann Karmanos Cancer Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place